Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06241430 · ClinicalTrials.gov registry record · NA
The CardioClip Study
A NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06241430 is a NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation that is actively recruiting participants, run by Columbia University. The registered enrollment target is 60 participants, below the 3,964-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06241430, a NA study of Heart Failure With Reduced Ejection Fraction and Mitral Regurgitation, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The CardioClip study is exploring the use of a wireless sensor to monitor pressure in the pulmonary artery. This sensor is inserted much like the mTEER procedure, a non-surgical method through a vein in the groin. The investigators want to find out if the sensor, by constantly sending information about heart function, can help improve patient outcomes. This means doctors could adjust medications based on real-time pressure changes detected by the sensor. The results from this study will help pave the way for future trials, asking if using these wireless sensors could benefit people with valve disease and heart failure.
Conditions Studied
Interventions
- DEVICE CardioMEMS
Study Locations (1)
New York
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-12-18 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06241430
The ClinicalTrials.gov registry entry for NCT06241430 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,964-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (98% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS is the first listed.
NCT06241430 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06241430 about?
NCT06241430 is a clinical study titled "The CardioClip Study". The CardioClip study is exploring the use of a wireless sensor to monitor pressure in the pulmonary artery. This sensor is inserted much like the mTEER procedure, a non-surgical method through a vein in the groin. The investigators want to find out if the sensor, by constantly sending information ab...
What is the current status of trial NCT06241430?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-12-18. Estimated completion is 2027-11.
What conditions does trial NCT06241430 study?
This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction, Mitral Regurgitation.
What interventions are being tested in trial NCT06241430?
The interventions under investigation include: CardioMEMS (DEVICE).
Who is sponsoring clinical trial NCT06241430?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06241430 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction
RECRUITING · NA
-
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure
RECRUITING · NA
-
Home-Based Cardiac Rehabilitation for Patients With Heart Failure
RECRUITING · NA
-
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
RECRUITING · NA
-
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
RECRUITING · NA
Explore more on PlainTrial
Heart Failure With Reduced Ejection Fraction
All registered trials for this condition
Mitral Regurgitation
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.